The role of the urologist in smoking cessation: Why is it important?

Urologic Oncology: Seminars and Original Investigations

Volumn 33, Issue 1, 2015, Pages 30-39

  Sosnowski, Roman ^a   Przewoźniak, Krzysztof ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Bladder cancer; Brief intervention; Smoking; Smoking cessation

Indexed keywords

ASSOCIATION; BLADDER CANCER; CANCER PREVENTION; CANCER PROGNOSIS; CANCER RISK; CORRELATION ANALYSIS; HUMAN; MEDICAL EDUCATION; OUTCOME ASSESSMENT; PATIENT EDUCATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME; UROLOGIST; ADVERSE EFFECTS; CASE CONTROL STUDY; MALE; PREVENTION AND CONTROL; PROCEDURES; PSYCHOLOGY; RISK FACTOR; STATISTICS AND NUMERICAL DATA; URINARY BLADDER NEOPLASMS; UROLOGY;

CASE-CONTROL STUDIES; HUMANS; MALE; RISK FACTORS; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; UROLOGY;

EID: 84922661272     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2014.07.011     Document Type: Review

References (65)

1. WHO. WHO Report on the Global Tobacco Epidemic, 2008 The MPOWER package. Geneva; 2008.
2. Jha P. Avoidable global cancer deaths and total deaths from smoking. Nat Rev Cancer 2009, 9:655-664.
3. Burger M., Catto J.W., Dalbagni G., Grossman H.B., Herr H., Karakiewicz P., et al. Epidemiology and risk factors of urothelial bladder cancer. Eur Urol 2013, 63:234-241.
4. Peto R., Lopez A., Boreham J., Thun M., Heath J.C. Mortality From Smoking in Developed Countries 1950-2010 2010, Oxford University Press, Oxford. http://www.ctsu.ox.ac.uk/research/mega-studies/mortality-from-smoking-in-developed-countries-1950-2010/mortality-from-smoking-in-developed-countries-1950-2010.
5. Boffetta P. Tobacco smoking and risk of bladder cancer. Scand J Urol Nephrol 2008, 218(Supplementum):45-54.
6. Stead L.F., Hartmann-Boyce J., Perera R., Lancaster T. Telephone counselling for smoking cessation. Cochrane Database Syst Rev 2013, 8:CD002850.
7. Aveyard P., Begh R., Parsons A., West R. Brief opportunistic smoking cessation interventions: a systematic review and meta-analysis to compare advice to quit and offer of assistance. Addiction 2012, 107:1066-1073.
8. Tong E.K., Ong M.K., Vittinghoff E., Perez-Stable E.J. Nondaily smokers should be asked and advised to quit. Am J Prev Med 2006, 30:23-30.
9. Hammond E.C., Horn D. Smoking and death rates: report on forty-four months of follow-up of 187,783 men. 2. Death rates by cause. J Am Med Assoc 1958, 166:1294-1308.
10. Tabaco smoking. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans Preamble. 1986;39:13-32.
11. Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. 2004;83 [49-1413].
12. Gandini S., Botteri E., Iodice S., Boniol M., Lowenfels A.B., Maisonneuve P., et al. Tobacco smoking and cancer: a meta-analysis. Int J Cancer 2008, 122:155-164.
13. Puente D., Hartge P., Greiser E., Cantor K.P., King W.D., Gonzalez C.A., et al. A pooled analysis of bladder cancer case-control studies evaluating smoking in men and women. Cancer Causes Control 2006, 17:71-79.
14. Zeegers M.P., Tan F.E., Dorant E., van Den Brandt P.A. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 2000, 89:630-639.
15. Alberg A.J., Kouzis A., Genkinger J.M., Gallicchio L., Burke A.E., Hoffman S.C., et al. A prospective cohort study of bladder cancer risk in relation to active cigarette smoking and household exposure to secondhand cigarette smoke. Am J Epidemiol 2007, 165:660-666.
16. Brennan P., Bogillot O., Cordier S., Greiser E., Schill W., Vineis P., et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer 2000, 86:289-294.
17. van Roekel E.H., Cheng K.K., James N.D., Wallace D.M., Billingham L.J., Murray P.G., et al. Smoking is associated with lower age, higher grade, higher stage, and larger size of malignant bladder tumors at diagnosis. Int J Cancer 2013, 133:446-454.
18. Hinotsu S., Akaza H., Miki T., Fujimoto H., Shinohara N., Kikuchi E., et al. Bladder cancer develops 6 years earlier in current smokers: analysis of bladder cancer registry data collected by the cancer registration committee of the Japanese Urological Association. Int J Urol 2009, 16:64-69.
19. Crivelli J.J., Xylinas E., Kluth L.A., Rieken M., Rink M., Shariat S.F. Effect of smoking on outcomes of urothelial carcinoma: a systematic review of the literature. Eur Urol 2014, 65(4):742-754.
20. Fleshner N., Garland J., Moadel A., Herr H., Ostroff J., Trambert R., et al. Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer 1999, 86:2337-2345.
21. Lammers R.J., Witjes W.P., Hendricksen K., Caris C.T., Janzing-Pastors M.H., Witjes J.A. Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer. Eur Urol 2011, 60:713-720.
22. Rink M., Furberg H., Zabor E.C., Xylinas E., Babjuk M., Pycha A., et al. Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer. Eur Urol 2013, 63:724-732.
23. Sylvester R.J., Oosterlinck W., van der Meijden A.P. A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol 2004, 171:2186-2190. [quiz 435].
24. Aveyard P., Adab P., Cheng K.K., Wallace D.M., Hey K., Murphy M.F. Does smoking status influence the prognosis of bladder cancer? A systematic review. BJU Int 2002, 90:228-239.
25. Chen C.H., Shun C.T., Huang K.H., Huang C.Y., Tsai Y.C., Yu H.J., et al. Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer. BJU Int 2007, 100:281-286. [discussion 6].
26. Sylvester R.J., van der M.A., Lamm D.L. Intravesical bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 2002, 168:1964-1970.
27. Alexandroff A.B., Jackson A.M., O'Donnell M.A., James K. BCG immunotherapy of bladder cancer: 20 years on. Lancet 1999, 353:1689-1694.
28. Sfakianos J.P., Shariat S.F., Favaretto R.L., Rioja J., Herr H.W. Impact of smoking on outcomes after intravesical bacillus Calmette-Guerin therapy for urothelial carcinoma not invading muscle of the bladder. BJU Int 2011, 108:526-530.
29. Bostrom P.J., Alkhateeb S., Trottier G., Athanasopoulos P.Z., Mirtti T., Kortekangas H., et al. Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer. BJU Int 2012, 109:70-76.
30. Hafron J., Mitra N., Dalbagni G., Bochner B., Herr H., Donat S.M. Does body mass index affect survival of patients undergoing radical or partial cystectomy for bladder cancer?. J Urol 2005, 173:1513-1517.
31. Yafi F.A., Aprikian A.G., Chin J.L., Fradet Y., Izawa J., Estey E., et al. Contemporary outcomes of 2,287 patients with bladder cancer who were treated with radical cystectomy: a Canadian multicentre experience. BJU Int 2011, 108:539-545.
32. Rink M., Zabor E.C., Furberg H., Xylinas E., Ehdaie B., Novara G., et al. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. Eur Urol 2013, 64:456-464.
33. Doll R., Peto R., Boreham J., Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. Br Med J 2004, 328:1519.
34. Rink M., Xylinas E., Babjuk M., Hansen J., Pycha A., Comploj E., et al. Impact of smoking on outcomes of patients with a history of recurrent nonmuscle invasive bladder cancer. J Urol 2012, 188:2120-2127.
35. Lee C., Kim K.H., You D., Jeong I.G., Hong B., Hong J.H., et al. Smoking and survival after radical cystectomy for bladder cancer. Urology 2012, 80:1307-1312.
36. Nieder A.M., John S., Messina C.R., Granek I.A., Adler H.L. Are patients aware of the association between smoking and bladder cancer?. J Urol 2006, 176:2405-2408. [discussion 8].
37. Watson R.A., Sadeghi-Nejad H. Tobacco abuse and the urologist: time for a more proactive role. Urology 2011, 78:1219-1223.
38. Vilensky D., Lawrentschuk N., Hersey K., Fleshner N.E. A smoking cessation program as a resource for bladder cancer patients. Can Urol Assoc J 2012, 6:E167-E173.
39. Zhang Z.F., Sarkis A.S., Cordon-Cardo C., Dalbagni G., Melamed J., Aprikian A., et al. Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancer. Cancer Epidemiol Biomarkers Prev 1994, 3:19-24.
40. Helgason A.R., Lund K.E. General practitioners' perceived barriers to smoking cessation-results from four Nordic countries. Scand J Public Health 2002, 30:141-147.
41. Dearing J. Disease-centred advice for patients with superficial transitional cell carcinoma of the bladder. Ann R Coll Surg Engl 2005, 87:85-87.
42. Bjurlin M.A., Goble S.M., Hollowell C.M. Smoking cessation assistance for patients with bladder cancer: a national survey of American urologists. J Urol 2010, 184:1901-1906.
43. Schroeder S.A. What to do with a patient who smokes. J Am Med Assoc 2005, 294:482-487.
44. Bjurlin M.A., Cohn M.R., Kim D.Y., Freeman V.L., Lombardo L., Hurley S.D., et al. Brief smoking cessation intervention: a prospective trial in the urology setting. J Urol 2013, 189:1843-1849.
45. Fagerstrom K.O. A comparison of psychological and pharmacological treatment in smoking cessation. J Behav Med 1982, 5:343-351.
46. Glynn T.J., Manley M.W., Pechacek T.F. Physician-initiated smoking cessation program: the National Cancer Institute trials. Prog Clin Biol Res 1990, 339:11-25.
47. Fiore M.C., Jaén C.R., Baker T.B. Treating tobacco use and dependence: 2008 update. Quick Reference Guide for Clinicians 2009, Public Health Service, U.S. Department of Health and Human Services, Rockville, MD.
48. Ockene J.K., Kristeller J., Goldberg R., Amick T.L., Pekow P.S., Hosmer D., et al. Increasing the efficacy of physician-delivered smoking interventions: a randomized clinical trial. J Gen Intern Med 1991, 6:1-8.
49. Gratziou C. Respiratory, cardiovascular and other physiological consequences of smoking cessation. Curr Med Res Opin 2009, 25:535-545.
50. Gritz E.R., Fingeret M.C., Vidrine D.J., Lazev A.B., Mehta N.V., Reece G.P. Successes and failures of the teachable moment: smoking cessation in cancer patients. Cancer 2006, 106:17-27.
51. Bassett J.C., Gore J.L., Chi A.C., Kwan L., McCarthy W., Chamie K., et al. Impact of a bladder cancer diagnosis on smoking behavior. J Clin Oncol 2012, 30:1871-1878.
52. The European Code Against Cancer; 2014.
53. Respir Care 2008, 53:1217-1222. Treating tobacco use and dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline executive summary.
54. Raw M., Anderson P., Batra A., Dubois G., Harrington P., Hirsch A., et al. WHO Europe evidence based recommendations on the treatment of tobacco dependence. Tob Control 2002, 11:44-46.
55. Bauld L., Judge K., Platt S. Assessing the impact of smoking cessation services on reducing health inequalities in England: observational study. Tob Control 2007, 16:400-404.
56. Boldemann C., Gilljam H., Lund K.E., Helgason A.R. Smoking cessation in general practice: the effects of a quitline. Nicotine Tob Res 2006, 8:785-790.
57. Bennett S., Fullard B., Hajek P., McNeill A., Milner D., Owen L., et al. Standard for Training in Smoking Cessation Treatments 2003, National Health Service. Health Development Agency, London.
58. Gutierrez K., Newcombe R. Lessons Learned Globally: Tobacco Control Digital Media Campaigns 2012, Global Dialogue for Effective Stop-Smoking Campaigns, Saint Paul. Minnesota. United States, http://global.tobaccofreekids.org/files/global_dialogue/Digital_Media_Campaign_Review_FINAL.pdf.
59. Cancer Facts & Figures 2014. American Cancer Society; 2014.
60. No Smoking Day British Heart Foundation 2013 Available from: 2014. http://www.nosmokingday.org.uk/.
61. Let's Stop Smoking Together: Cancer Center and Institute. Warsaw, Poland. Available from: 2014. Accessed 02.01.14. http://jakrzucicpalenie.pl/.
62. World No Tobacco Day: World Health Organization, Prevention of Noncommunicable Diseases and Mental Health. Available from: 2014. Accessed 02.01.14. http://www.who.int/tobacco/wntd/en/.
63. HELP-For a Life Without Tobacco: European Commission. Available from: 2010. Accessed 02.01.14. http://ec.europa.eu/health/tobacco/events/help_events_en.htm.
64. Ex-Smokers Are Unstoppable: European Commission. Available from: 2013. Accessed 02.01.14. http://ec.europa.eu/health/tobacco/ex_smokers_are_unstoppable/index_en.htm.
65. Every Cigarette is Doing You Damage: Commonwealth of Australia. Available from: 2000. http://www.health.gov.au/internet/main/publishing.nsf/Content/724A2D79EB8761C5CA257BF0001F3FBE/$File/tobccamp_2.pdf.